The depolarization of NLC with other M1 agents, such as IFN-γ and LPS, also changed the final polarization of NLC, but with a distinct pattern and effect on the viability of CLL cells. The gene discussed is IFNG; the disease is B-cell chronic lymphocytic leukemia.